Webinar
AI as a strategic asset across the product lifecycle
AI Summer Series Webinar
Artificial intelligence (AI) is rapidly becoming a strategic asset across the product lifecycle—not just a back‑office efficiency tool. When grounded in strong governance, domain expertise, and real‑world application, AI can support more informed decision‑making across regulatory, pharmacovigilance, and value, evidence, and access. Watch the recording to discover how AI is being applied across regulated and market‑facing functions to move beyond compliance‑driven execution toward more proactive, strategic contributions.
Artificial intelligence (AI) is rapidly becoming a strategic asset across the product lifecycle—not just a back‑office efficiency tool. When grounded in strong governance, domain expertise, and real‑world application, AI can support more informed decision‑making across regulatory, pharmacovigilance, and value, evidence, and access. Watch the recording to discover how AI is being applied across regulated and market‑facing functions to move beyond compliance‑driven execution toward more proactive, strategic contributions.
Key highlights
- Where AI creates real value: How AI can support decisions, evidence, and execution across regulatory, pharmacovigilance, and access—from early planning through post‑market stages.
- Lifecycle opportunity map: A practical view of where AI can be applied to enable more coordinated, insight‑driven outcomes.
- Responsible adoption in practice: The governance, data, and leadership considerations that help organizations prioritize, align, and scale AI in a controlled, impact‑oriented way.
Moderator:
Chris Englerth, Director of Global Consulting Services, Cencora
Speakers:
Kristen Jacobs, SVP, Regulatory, Compliance and Pharmacovigilance, Cencora
Tommy Bramley, SVP, Value, Evidence and Access, Cencora
Access now to explore AI across regulated pharma functions
